ET Wealth's 5 must-reads: 4 pharma companies with up to 20% upside potential, how to lose money in the stock market, and more Learn if you should invest in small financing bank stocks, how to lose money in the stock market, and why HDFC Life is this week's stock selection

This week's top six stories from ET Wealth are listed below


Here is a curated list of the best ET Wealth stories of the week. We take a look at small finance bank stocks that can be the next wealth multipliers, 4 pharma stocks with up to 20% upside potential, how gains made on startup investments will be taxed, 4 pharma stocks worth betting on and more.

1) Can any small finance bank be the next HDFC Bank?
As the new chapter in Indian banking has started, is there another opportunity for equity investors to benefit from this model? If yes, which stock is the best for you to invest for the long term?

2) How investors end up earning lesser than the investments they make
We investors are our own worst enemies. On the one hand, we are obsessed with choosing the best mutual fund to invest in. On the other, we buy and sell funds at exactly the wrong time, in a manner guaranteed to reduce our returns.

3) 4 pharma stocks with up to 20% upside potential
Here is a list four pharma companies with good analyst recommendations and double-digit one-year price potential.

4) How small investors can put money in startups, how gains made on investments will be taxed
Some platforms are helping small investors get a foothold in the very-high-risk-very-high-reward world of startup investing.

5) 4 reasons analysts are bullish on HDFC Life
Higher awareness of the need for protection and India's changing demographic, with a rising proportion of insurable population, will boost expansion for HDFC Life Insurance.
Filed under